In recent years, we have witnessed a paradigm shift in cardiometabolic medicine: The SELECT trial demonstrated that GLP-1 receptor agonists reduce cardiovascular events even in patients without diabetes
A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infaction
Compounding pharmacies have historically been allowed to produce custom formulations under section 503A (individual prescriptions) and section 503B (outsourcing facilities with batch production) of the Federal Food, Drug, and Cosmetic Act
Obesity, hypoglycemia, and CVD risk are important considerations in the treatment of T2DM, and interventions aimed at reducing chronic micro and macrovascular complications and improving cardiorenal outcomes are of paramount importance (7)
Many find the best results by taking L-carnitine about 30 to 60 minutes before a workout or with a meal